Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm.
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm. Blood. 2010 Oct 07; 116(14):2420-8.
View in:
PubMed
subject areas
Clinical Trials, Phase II as Topic
Clinical Trials, Phase III as Topic
Drug Discovery
Humans
Leukemia, Myeloid, Acute
authors with profiles
Richard A. Larson